Redox Limited (ASX:RDX)
Australia · Delayed Price · Currency is AUD | Market Cap | 1.84B +25.4% |
| Revenue (ttm) | 1.29B +8.3% |
| Net Income | 80.68M -11.2% |
| EPS | 0.15 -11.4% |
| Shares Out | 525.08M |
| PE Ratio | 22.83 |
| Forward PE | 21.59 |
| Dividend | 0.13 (3.57%) |
| Ex-Dividend Date | Mar 3, 2026 |
| Volume | 543,919 |
| Open | 3.400 |
| Previous Close | 3.400 |
| Day's Range | 3.390 - 3.510 |
| 52-Week Range | 2.015 - 3.520 |
| Beta | -0.37 |
| Analysts | Buy |
| Price Target | 3.64 (+4.0%) |
| Earnings Date | Aug 21, 2026 |
About Dialog Axiata
Redox Limited supplies and distributes chemicals, ingredients, and raw materials in Australia, New Zealand, the United States, and internationally. It offers antioxidants, proteins and fibres, leaving agents, acidity regulator, sweeteners, thickeners, stabilisers and gums, vitamins, amino acids, mineral salts, preservatives, phosphates, humectants, essential and vegetable oils, herb and spice extracts, natural colours, emulsifier, dairy products, wine and brewing, cleaning and sanitation, specialities, additives, chemicals, emollients, emulsifi... [Read more]
Financial Performance
In fiscal year 2025, Redox's revenue was 1.24 billion, an increase of 9.36% compared to the previous year's 1.14 billion. Earnings were 77.10 million, a decrease of -14.56%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for RDX stock is "Buy." The 12-month stock price target is $3.64, which is an increase of 4.00% from the latest price.
News
Redox Earnings Call Transcript: H1 2026
Sales grew 6.6% to AUD 674 million, with strong industrial and food segment gains and robust North American performance. Gross profit and EPS rose, supported by disciplined costs and a strong net cash position, while management anticipates upward pricing pressure and continued M&A activity.
Redox Quarterly report: H1 2026
Redox has published its H1 2026 quarterly earnings report on February 18, 2026.
Redox Slides: H1 2026
Redox has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 18, 2026.
Redox Transcript: AGM 2025
The meeting highlighted strong financial growth, a robust dividend, and successful acquisitions expanding both product range and geographic reach. Board governance, ESG commitments, and strategic focus on North America were emphasized, with all resolutions passed and key risks around market conditions and culture addressed.
Redox Slides: FY 2025
Redox has posted slides in relation to its FY 2025 quarterly earnings report, which was published on October 7, 2025.
Redox Earnings Call Transcript: H2 2025
FY 2025 delivered 9.4% revenue growth and strong cash generation despite subdued demand and cost pressures. Three acquisitions and organic expansion drove segment growth, with July 2025 sales and volumes up 13% year-over-year, signaling a positive start to FY 2026.
Redox Annual report: H2 2025
Redox has published its H2 2025 annual report on August 20, 2025.
Redox Slides: H2 2025
Redox has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 20, 2025.